nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—Fibroadenosis of breast—Cyclosporine—focal segmental glomerulosclerosis	0.0281	0.033	CcSEcCtD
Ropinirole—Fibroadenoma of breast—Cyclosporine—focal segmental glomerulosclerosis	0.0262	0.0308	CcSEcCtD
Ropinirole—Vestibular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0189	0.0222	CcSEcCtD
Ropinirole—Tonsillitis—Cyclosporine—focal segmental glomerulosclerosis	0.015	0.0177	CcSEcCtD
Ropinirole—Hyperkeratosis—Cyclosporine—focal segmental glomerulosclerosis	0.0133	0.0156	CcSEcCtD
Ropinirole—Benign intracranial hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.0129	0.0152	CcSEcCtD
Ropinirole—Carcinoma—Cyclosporine—focal segmental glomerulosclerosis	0.0126	0.0148	CcSEcCtD
Ropinirole—Rheumatoid arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0126	0.0148	CcSEcCtD
Ropinirole—Skin cancer—Cyclosporine—focal segmental glomerulosclerosis	0.0123	0.0144	CcSEcCtD
Ropinirole—Uterine haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.0128	CcSEcCtD
Ropinirole—Non-Hodgkin's lymphoma—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.0128	CcSEcCtD
Ropinirole—Lymphoma—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.0128	CcSEcCtD
Ropinirole—Goitre—Cyclosporine—focal segmental glomerulosclerosis	0.0106	0.0125	CcSEcCtD
Ropinirole—Peripheral ischaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0104	0.0122	CcSEcCtD
Ropinirole—Paresis—Cyclosporine—focal segmental glomerulosclerosis	0.0104	0.0122	CcSEcCtD
Ropinirole—Pyelonephritis—Cyclosporine—focal segmental glomerulosclerosis	0.01	0.0117	CcSEcCtD
Ropinirole—Bullous eruption—Cyclosporine—focal segmental glomerulosclerosis	0.00962	0.0113	CcSEcCtD
Ropinirole—Pancreatitis acute—Cyclosporine—focal segmental glomerulosclerosis	0.00823	0.00966	CcSEcCtD
Ropinirole—Bacterial infection—Cyclosporine—focal segmental glomerulosclerosis	0.00823	0.00966	CcSEcCtD
Ropinirole—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.00787	0.00923	CcSEcCtD
Ropinirole—Muscle contractions involuntary—Cyclosporine—focal segmental glomerulosclerosis	0.00787	0.00923	CcSEcCtD
Ropinirole—Myositis—Cyclosporine—focal segmental glomerulosclerosis	0.00775	0.0091	CcSEcCtD
Ropinirole—Azotaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00714	0.00837	CcSEcCtD
Ropinirole—Ear disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00704	0.00827	CcSEcCtD
Ropinirole—Night sweats—Cyclosporine—focal segmental glomerulosclerosis	0.00704	0.00827	CcSEcCtD
Ropinirole—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.00687	0.00806	CcSEcCtD
Ropinirole—Gingival bleeding—Cyclosporine—focal segmental glomerulosclerosis	0.0067	0.00786	CcSEcCtD
Ropinirole—Gastric ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00654	0.00768	CcSEcCtD
Ropinirole—Cerebration impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00647	0.00759	CcSEcCtD
Ropinirole—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00647	0.00759	CcSEcCtD
Ropinirole—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.00625	0.00733	CcSEcCtD
Ropinirole—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.00605	0.0071	CcSEcCtD
Ropinirole—Folliculitis—Cyclosporine—focal segmental glomerulosclerosis	0.00605	0.0071	CcSEcCtD
Ropinirole—Tooth disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00586	0.00688	CcSEcCtD
Ropinirole—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00586	0.00688	CcSEcCtD
Ropinirole—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00569	0.00667	CcSEcCtD
Ropinirole—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00558	0.00655	CcSEcCtD
Ropinirole—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00547	0.00642	CcSEcCtD
Ropinirole—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.00537	0.0063	CcSEcCtD
Ropinirole—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.00537	0.0063	CcSEcCtD
Ropinirole—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00532	0.00625	CcSEcCtD
Ropinirole—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00523	0.00613	CcSEcCtD
Ropinirole—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00505	0.00593	CcSEcCtD
Ropinirole—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.00492	0.00578	CcSEcCtD
Ropinirole—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00488	0.00573	CcSEcCtD
Ropinirole—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00488	0.00573	CcSEcCtD
Ropinirole—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00484	0.00568	CcSEcCtD
Ropinirole—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.00484	0.00568	CcSEcCtD
Ropinirole—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00484	0.00568	CcSEcCtD
Ropinirole—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.0048	0.00564	CcSEcCtD
Ropinirole—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.00466	0.00546	CcSEcCtD
Ropinirole—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.00452	0.0053	CcSEcCtD
Ropinirole—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.00452	0.0053	CcSEcCtD
Ropinirole—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.00445	0.00523	CcSEcCtD
Ropinirole—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.00439	0.00515	CcSEcCtD
Ropinirole—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00433	0.00508	CcSEcCtD
Ropinirole—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00433	0.00508	CcSEcCtD
Ropinirole—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00424	0.00497	CcSEcCtD
Ropinirole—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00421	0.00494	CcSEcCtD
Ropinirole—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00421	0.00494	CcSEcCtD
Ropinirole—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00418	0.00491	CcSEcCtD
Ropinirole—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00418	0.00491	CcSEcCtD
Ropinirole—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00418	0.00491	CcSEcCtD
Ropinirole—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00418	0.00491	CcSEcCtD
Ropinirole—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00413	0.00484	CcSEcCtD
Ropinirole—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00413	0.00484	CcSEcCtD
Ropinirole—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0041	0.00481	CcSEcCtD
Ropinirole—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.0041	0.00481	CcSEcCtD
Ropinirole—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00407	0.00478	CcSEcCtD
Ropinirole—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00399	0.00469	CcSEcCtD
Ropinirole—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00399	0.00469	CcSEcCtD
Ropinirole—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00387	0.00454	CcSEcCtD
Ropinirole—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.0038	0.00446	CcSEcCtD
Ropinirole—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.0038	0.00446	CcSEcCtD
Ropinirole—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00374	0.00438	CcSEcCtD
Ropinirole—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00374	0.00438	CcSEcCtD
Ropinirole—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00369	0.00433	CcSEcCtD
Ropinirole—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00367	0.00431	CcSEcCtD
Ropinirole—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00367	0.00431	CcSEcCtD
Ropinirole—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00363	0.00426	CcSEcCtD
Ropinirole—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00361	0.00424	CcSEcCtD
Ropinirole—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.00359	0.00421	CcSEcCtD
Ropinirole—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00357	0.00419	CcSEcCtD
Ropinirole—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00349	0.0041	CcSEcCtD
Ropinirole—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00347	0.00408	CcSEcCtD
Ropinirole—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00347	0.00408	CcSEcCtD
Ropinirole—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00344	0.00403	CcSEcCtD
Ropinirole—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00344	0.00403	CcSEcCtD
Ropinirole—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.0034	0.00399	CcSEcCtD
Ropinirole—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00332	0.00389	CcSEcCtD
Ropinirole—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.0033	0.00387	CcSEcCtD
Ropinirole—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.0033	0.00387	CcSEcCtD
Ropinirole—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00323	0.0038	CcSEcCtD
Ropinirole—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00317	0.00372	CcSEcCtD
Ropinirole—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00314	0.00369	CcSEcCtD
Ropinirole—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00311	0.00365	CcSEcCtD
Ropinirole—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00308	0.00362	CcSEcCtD
Ropinirole—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00308	0.00362	CcSEcCtD
Ropinirole—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00308	0.00362	CcSEcCtD
Ropinirole—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00307	0.0036	CcSEcCtD
Ropinirole—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00306	0.00359	CcSEcCtD
Ropinirole—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00298	0.00349	CcSEcCtD
Ropinirole—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00295	0.00346	CcSEcCtD
Ropinirole—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00294	0.00345	CcSEcCtD
Ropinirole—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00292	0.00343	CcSEcCtD
Ropinirole—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00291	0.00342	CcSEcCtD
Ropinirole—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00289	0.00339	CcSEcCtD
Ropinirole—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00286	0.00336	CcSEcCtD
Ropinirole—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.00333	CcSEcCtD
Ropinirole—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00283	0.00332	CcSEcCtD
Ropinirole—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00283	0.00332	CcSEcCtD
Ropinirole—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00282	0.00331	CcSEcCtD
Ropinirole—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.00324	CcSEcCtD
Ropinirole—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00274	0.00321	CcSEcCtD
Ropinirole—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00272	0.00319	CcSEcCtD
Ropinirole—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00272	0.00319	CcSEcCtD
Ropinirole—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00261	0.00307	CcSEcCtD
Ropinirole—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00253	0.00297	CcSEcCtD
Ropinirole—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00252	0.00296	CcSEcCtD
Ropinirole—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00249	0.00293	CcSEcCtD
Ropinirole—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00249	0.00292	CcSEcCtD
Ropinirole—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.00287	CcSEcCtD
Ropinirole—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00243	0.00286	CcSEcCtD
Ropinirole—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.0024	0.00282	CcSEcCtD
Ropinirole—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00239	0.0028	CcSEcCtD
Ropinirole—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00234	0.00274	CcSEcCtD
Ropinirole—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00232	0.00273	CcSEcCtD
Ropinirole—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.00269	CcSEcCtD
Ropinirole—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.00268	CcSEcCtD
Ropinirole—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00262	CcSEcCtD
Ropinirole—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.0026	CcSEcCtD
Ropinirole—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.0022	0.00259	CcSEcCtD
Ropinirole—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00217	0.00255	CcSEcCtD
Ropinirole—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.00253	CcSEcCtD
Ropinirole—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00215	0.00253	CcSEcCtD
Ropinirole—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00214	0.00251	CcSEcCtD
Ropinirole—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00213	0.0025	CcSEcCtD
Ropinirole—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00213	0.0025	CcSEcCtD
Ropinirole—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00212	0.00249	CcSEcCtD
Ropinirole—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.00246	CcSEcCtD
Ropinirole—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00208	0.00245	CcSEcCtD
Ropinirole—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00208	0.00245	CcSEcCtD
Ropinirole—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.00243	CcSEcCtD
Ropinirole—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.00243	CcSEcCtD
Ropinirole—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.00243	CcSEcCtD
Ropinirole—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.00238	CcSEcCtD
Ropinirole—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00201	0.00236	CcSEcCtD
Ropinirole—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00201	0.00235	CcSEcCtD
Ropinirole—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.00234	CcSEcCtD
Ropinirole—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.00225	CcSEcCtD
Ropinirole—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00225	CcSEcCtD
Ropinirole—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00224	CcSEcCtD
Ropinirole—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.00223	CcSEcCtD
Ropinirole—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.00222	CcSEcCtD
Ropinirole—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.00221	CcSEcCtD
Ropinirole—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.0022	CcSEcCtD
Ropinirole—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.0022	CcSEcCtD
Ropinirole—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00184	0.00216	CcSEcCtD
Ropinirole—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00178	0.00209	CcSEcCtD
Ropinirole—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00208	CcSEcCtD
Ropinirole—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00173	0.00203	CcSEcCtD
Ropinirole—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00202	CcSEcCtD
Ropinirole—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.00201	CcSEcCtD
Ropinirole—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.002	CcSEcCtD
Ropinirole—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.00198	CcSEcCtD
Ropinirole—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.00196	CcSEcCtD
Ropinirole—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.00195	CcSEcCtD
Ropinirole—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00192	CcSEcCtD
Ropinirole—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.00191	CcSEcCtD
Ropinirole—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.00191	CcSEcCtD
Ropinirole—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00189	CcSEcCtD
Ropinirole—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00188	CcSEcCtD
Ropinirole—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.00184	CcSEcCtD
Ropinirole—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.00183	CcSEcCtD
Ropinirole—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.00181	CcSEcCtD
Ropinirole—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.0018	CcSEcCtD
Ropinirole—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00179	CcSEcCtD
Ropinirole—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.00178	CcSEcCtD
Ropinirole—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.00176	CcSEcCtD
Ropinirole—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.00175	CcSEcCtD
Ropinirole—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.00175	CcSEcCtD
Ropinirole—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.0017	CcSEcCtD
Ropinirole—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00169	CcSEcCtD
Ropinirole—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00168	CcSEcCtD
Ropinirole—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00166	CcSEcCtD
Ropinirole—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00166	CcSEcCtD
Ropinirole—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00166	CcSEcCtD
Ropinirole—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00165	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00165	CcSEcCtD
Ropinirole—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00164	CcSEcCtD
Ropinirole—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.00162	CcSEcCtD
Ropinirole—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00161	CcSEcCtD
Ropinirole—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00159	CcSEcCtD
Ropinirole—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.00158	CcSEcCtD
Ropinirole—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00156	CcSEcCtD
Ropinirole—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00156	CcSEcCtD
Ropinirole—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.00155	CcSEcCtD
Ropinirole—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00154	CcSEcCtD
Ropinirole—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00152	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00145	CcSEcCtD
Ropinirole—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00144	CcSEcCtD
Ropinirole—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00143	CcSEcCtD
Ropinirole—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00142	CcSEcCtD
Ropinirole—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00142	CcSEcCtD
Ropinirole—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.0014	CcSEcCtD
Ropinirole—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00138	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00137	CcSEcCtD
Ropinirole—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00137	CcSEcCtD
Ropinirole—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00136	CcSEcCtD
Ropinirole—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00136	CcSEcCtD
Ropinirole—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00131	CcSEcCtD
Ropinirole—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.0013	CcSEcCtD
Ropinirole—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00126	CcSEcCtD
Ropinirole—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00126	CcSEcCtD
Ropinirole—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00126	CcSEcCtD
Ropinirole—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000999	0.00117	CcSEcCtD
Ropinirole—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000973	0.00114	CcSEcCtD
Ropinirole—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00096	0.00113	CcSEcCtD
Ropinirole—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000928	0.00109	CcSEcCtD
Ropinirole—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000897	0.00105	CcSEcCtD
Ropinirole—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000862	0.00101	CcSEcCtD
Ropinirole—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000855	0.001	CcSEcCtD
Ropinirole—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000854	0.001	CcSEcCtD
Ropinirole—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00085	0.000997	CcSEcCtD
Ropinirole—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000806	0.000946	CcSEcCtD
Ropinirole—HTR2B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000108	0.00073	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000108	0.000727	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000107	0.000726	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000107	0.000723	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000107	0.000722	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000107	0.000721	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000107	0.00072	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000105	0.000713	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000105	0.000709	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000105	0.000708	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000104	0.000705	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000104	0.000704	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000104	0.000704	CbGpPWpGaD
Ropinirole—ADRA2C—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000103	0.000696	CbGpPWpGaD
Ropinirole—ADRA2C—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000103	0.000695	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000103	0.000694	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000103	0.000693	CbGpPWpGaD
Ropinirole—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.000103	0.000693	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000102	0.00069	CbGpPWpGaD
Ropinirole—DRD1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000102	0.000688	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000101	0.000686	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000101	0.000682	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000101	0.00068	CbGpPWpGaD
Ropinirole—DRD3—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.0001	0.000679	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.0001	0.000677	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	9.96e-05	0.000673	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—NOS2—focal segmental glomerulosclerosis	9.94e-05	0.000672	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	9.92e-05	0.000671	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	9.92e-05	0.00067	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	9.9e-05	0.000669	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	9.8e-05	0.000663	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.78e-05	0.000661	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	9.78e-05	0.000661	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	9.76e-05	0.00066	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	9.71e-05	0.000656	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.61e-05	0.000649	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.58e-05	0.000647	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	9.58e-05	0.000647	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	9.53e-05	0.000644	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.42e-05	0.000637	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	9.33e-05	0.00063	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	9.27e-05	0.000626	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	9.26e-05	0.000626	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	9.24e-05	0.000625	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	9.23e-05	0.000624	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—CTGF—focal segmental glomerulosclerosis	9.16e-05	0.000619	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	9.12e-05	0.000616	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	9.11e-05	0.000616	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.1e-05	0.000615	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	9.07e-05	0.000613	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	9.04e-05	0.000611	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9e-05	0.000608	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	8.99e-05	0.000608	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	8.95e-05	0.000605	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	8.88e-05	0.0006	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	8.76e-05	0.000592	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	8.75e-05	0.000592	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	8.73e-05	0.00059	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	8.71e-05	0.000589	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	8.68e-05	0.000587	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	8.68e-05	0.000587	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	8.63e-05	0.000584	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	8.62e-05	0.000583	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	8.48e-05	0.000573	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	8.47e-05	0.000572	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—LIPC—focal segmental glomerulosclerosis	8.45e-05	0.000571	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	8.44e-05	0.000571	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.44e-05	0.000571	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	8.41e-05	0.000568	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	8.4e-05	0.000568	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	8.37e-05	0.000566	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	8.37e-05	0.000566	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—ALB—focal segmental glomerulosclerosis	8.35e-05	0.000565	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	8.29e-05	0.00056	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	8.27e-05	0.000559	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	8.23e-05	0.000557	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	8.23e-05	0.000556	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.22e-05	0.000555	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	7.95e-05	0.000537	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	7.91e-05	0.000534	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	7.76e-05	0.000524	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	7.69e-05	0.00052	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	7.68e-05	0.000519	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	7.66e-05	0.000518	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	7.66e-05	0.000518	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	7.62e-05	0.000515	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.59e-05	0.000513	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.58e-05	0.000513	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	7.56e-05	0.000511	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	7.56e-05	0.000511	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	7.54e-05	0.00051	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	7.53e-05	0.000509	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	7.5e-05	0.000507	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—CTGF—focal segmental glomerulosclerosis	7.44e-05	0.000503	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.43e-05	0.000502	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.36e-05	0.000497	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.31e-05	0.000494	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	7.3e-05	0.000493	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	7.26e-05	0.000491	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.2e-05	0.000487	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.09e-05	0.000479	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	7.06e-05	0.000477	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	6.98e-05	0.000472	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	6.98e-05	0.000472	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.97e-05	0.000471	CbGpPWpGaD
Ropinirole—ADRA2B—Hemostasis—TGFB1—focal segmental glomerulosclerosis	6.96e-05	0.000471	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.91e-05	0.000467	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	6.88e-05	0.000465	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	6.87e-05	0.000464	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	6.86e-05	0.000464	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.86e-05	0.000464	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.82e-05	0.000461	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	6.82e-05	0.000461	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.77e-05	0.000457	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.71e-05	0.000454	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.67e-05	0.000451	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.64e-05	0.000449	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	6.58e-05	0.000445	CbGpPWpGaD
Ropinirole—ADRA2C—Hemostasis—TGFB1—focal segmental glomerulosclerosis	6.5e-05	0.00044	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	6.49e-05	0.000439	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.46e-05	0.000436	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.41e-05	0.000433	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.41e-05	0.000433	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	6.39e-05	0.000432	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.38e-05	0.000431	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—LPL—focal segmental glomerulosclerosis	6.35e-05	0.000429	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.32e-05	0.000427	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.3e-05	0.000426	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.3e-05	0.000426	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.29e-05	0.000425	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	6.25e-05	0.000422	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.16e-05	0.000417	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.07e-05	0.00041	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.04e-05	0.000409	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.96e-05	0.000403	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.86e-05	0.000396	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.86e-05	0.000396	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.82e-05	0.000393	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.79e-05	0.000391	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.76e-05	0.00039	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.73e-05	0.000388	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.7e-05	0.000385	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.69e-05	0.000384	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.66e-05	0.000382	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.63e-05	0.00038	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.6e-05	0.000379	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	5.51e-05	0.000372	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.49e-05	0.000371	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.47e-05	0.00037	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	5.47e-05	0.00037	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.46e-05	0.000369	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.46e-05	0.000369	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—AGT—focal segmental glomerulosclerosis	5.43e-05	0.000367	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.39e-05	0.000364	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.38e-05	0.000364	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.35e-05	0.000362	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.31e-05	0.000359	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	5.28e-05	0.000357	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.24e-05	0.000354	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.2e-05	0.000351	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.17e-05	0.00035	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	5.16e-05	0.000349	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.05e-05	0.000341	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.03e-05	0.00034	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.98e-05	0.000336	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.97e-05	0.000336	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.89e-05	0.00033	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.86e-05	0.000329	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	4.85e-05	0.000328	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.84e-05	0.000327	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.84e-05	0.000327	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.82e-05	0.000326	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.74e-05	0.00032	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.74e-05	0.00032	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.7e-05	0.000317	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.67e-05	0.000316	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	4.67e-05	0.000315	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.66e-05	0.000315	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.56e-05	0.000309	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.54e-05	0.000307	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.49e-05	0.000304	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.49e-05	0.000304	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.47e-05	0.000302	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.45e-05	0.000301	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.45e-05	0.000301	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	4.41e-05	0.000298	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.34e-05	0.000293	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.32e-05	0.000292	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.31e-05	0.000292	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.2e-05	0.000284	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.2e-05	0.000284	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.2e-05	0.000284	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—ALB—focal segmental glomerulosclerosis	4.17e-05	0.000282	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.14e-05	0.00028	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.12e-05	0.000279	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	4.11e-05	0.000278	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.09e-05	0.000276	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.06e-05	0.000274	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.99e-05	0.00027	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.81e-05	0.000257	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.79e-05	0.000256	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.75e-05	0.000253	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.74e-05	0.000253	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.71e-05	0.000251	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.69e-05	0.000249	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.63e-05	0.000245	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.61e-05	0.000244	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	3.6e-05	0.000243	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.59e-05	0.000243	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.57e-05	0.000241	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.49e-05	0.000236	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.41e-05	0.00023	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.41e-05	0.00023	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	3.39e-05	0.000229	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	3.36e-05	0.000227	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.22e-05	0.000217	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.17e-05	0.000214	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	3.17e-05	0.000214	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.17e-05	0.000214	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.12e-05	0.000211	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.06e-05	0.000207	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.99e-05	0.000202	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.94e-05	0.000199	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.92e-05	0.000197	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	2.88e-05	0.000194	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.86e-05	0.000194	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	2.85e-05	0.000192	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.84e-05	0.000192	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.81e-05	0.00019	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.77e-05	0.000187	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.75e-05	0.000186	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.68e-05	0.000181	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.65e-05	0.000179	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.61e-05	0.000177	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	2.44e-05	0.000165	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.43e-05	0.000164	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.39e-05	0.000161	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.36e-05	0.00016	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.28e-05	0.000154	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.27e-05	0.000153	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	2.21e-05	0.000149	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.21e-05	0.000149	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	2.2e-05	0.000149	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.17e-05	0.000147	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2e-05	0.000135	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.97e-05	0.000133	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	1.88e-05	0.000127	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	1.87e-05	0.000126	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.79e-05	0.000121	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	1.44e-05	9.75e-05	CbGpPWpGaD
